173 related articles for article (PubMed ID: 17303012)
1. The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering.
Christ G; Andersson KE; Atala A
Curr Urol Rep; 2007 Mar; 8(2):95-9. PubMed ID: 17303012
[No Abstract] [Full Text] [Related]
2. Regenerative medicine and urology.
Atala A
BJU Int; 2003 Oct; 92 Suppl 1():58-67. PubMed ID: 12969012
[No Abstract] [Full Text] [Related]
3. Current formulations and techniques of drug/gene delivery for targeted therapy and tissue engineering.
Wang CH; Ranganath SH
Curr Pharm Des; 2010 Jul; 16(21):2296-7. PubMed ID: 20618150
[No Abstract] [Full Text] [Related]
4. Bladder regeneration by tissue engineering.
Atala A
BJU Int; 2001 Nov; 88(7):765-70. PubMed ID: 11890251
[No Abstract] [Full Text] [Related]
5. Editorial: Nanotechnology for advanced therapy and diagnosis.
Sprintz M
Biomed Microdevices; 2004 Jun; 6(2):101-3. PubMed ID: 15320630
[No Abstract] [Full Text] [Related]
6. Gene therapy and tissue engineering for urologic dysfunction: status and prospects.
Yokoyama T; Chancellor MB; Yoshimura N; Huard J; Kumon H
Mol Urol; 2001; 5(2):67-70. PubMed ID: 11690550
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in intravesical drug/gene delivery.
Tyagi P; Wu PC; Chancellor M; Yoshimura N; Huang L
Mol Pharm; 2006; 3(4):369-79. PubMed ID: 16889430
[TBL] [Abstract][Full Text] [Related]
8. Future trends in bladder reconstructive surgery.
Atala A
Semin Pediatr Surg; 2002 May; 11(2):134-42. PubMed ID: 11973766
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE).
Yoshimura N; Franks ME; Sasaki K; Goins WF; Goss J; Yokoyama T; Fraser MO; Seki S; Fink J; Glorioso J; de Groat WC; Chancellor MB
Urology; 2001 Jun; 57(6 Suppl 1):116. PubMed ID: 11378092
[No Abstract] [Full Text] [Related]
10. Engineering functional bladder tissues.
Horst M; Madduri S; Gobet R; Sulser T; Milleret V; Hall H; Atala A; Eberli D
J Tissue Eng Regen Med; 2013 Jul; 7(7):515-22. PubMed ID: 22438261
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer strategies in tissue engineering.
Bleiziffer O; Eriksson E; Yao F; Horch RE; Kneser U
J Cell Mol Med; 2007; 11(2):206-23. PubMed ID: 17488473
[TBL] [Abstract][Full Text] [Related]
12. Improving conservative treatment of overactive bladder and urge incontinence--1 small step at a time.
Nitti VW
J Urol; 2001 Jul; 166(1):150-1. PubMed ID: 11435844
[No Abstract] [Full Text] [Related]
13. Prospects for engineering the urinary tract.
Koh CJ; Atala A
Nephron Exp Nephrol; 2004; 98(3):e65-70. PubMed ID: 15528946
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of the overactive bladder.
Wein AJ
Urology; 2003 Nov; 62(5 Suppl 2):20-7. PubMed ID: 14662403
[TBL] [Abstract][Full Text] [Related]
15. Waterworks.
Persson PB
Acta Physiol (Oxf); 2015 Jun; 214(2):147-8. PubMed ID: 25882508
[No Abstract] [Full Text] [Related]
16. Bladder tissue-engineering: a new practical solution?
Chung SY
Lancet; 2006 Apr; 367(9518):1215-6. PubMed ID: 16631860
[No Abstract] [Full Text] [Related]
17. Biomedical engineering for health research and development.
Zhang XY
Eur Rev Med Pharmacol Sci; 2015; 19(2):220-4. PubMed ID: 25683934
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured materials for applications in drug delivery and tissue engineering.
Goldberg M; Langer R; Jia X
J Biomater Sci Polym Ed; 2007; 18(3):241-68. PubMed ID: 17471764
[TBL] [Abstract][Full Text] [Related]
19. Importance of controlled delivery systems for regenerative therapeutics.
Khang G; Tripathy N
Ther Deliv; 2014 Oct; 5(10):1053-5. PubMed ID: 25418264
[No Abstract] [Full Text] [Related]
20. Vesical prolapse in an apparently "normal" bladder.
Johal NS; Murphy F; Mushtaq I
J Pediatr Surg; 2007 Dec; 42(12):e1-2. PubMed ID: 18082682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
